<DOC>
	<DOC>NCT01317810</DOC>
	<brief_summary>The purpose of this study is to track changes in overactive bladder (OAB) medical regimen and/or OAB medication dosage requirements.</brief_summary>
	<brief_title>A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication</brief_title>
	<detailed_description>Subjects will complete a study specific survey questionnaire at Screening and the Month 1 through Month 6 visits. Subjects will be followed for 6 months.</detailed_description>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<criteria>Subject has overactive bladder as determined by their prescribing physician Subject is currently receiving pharmacotherapy for overactive bladder Subject is willing to comply with required protocol/study requirements Subject has a history of a clinically significant illness or medical condition prior to screening that would preclude participation in the study Male subjects with Lower Urinary Tract Symptoms (LUTS) or Bladder Outlet Obstruction (BOO)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Overactive Bladder (OAB)</keyword>
	<keyword>Observational</keyword>
	<keyword>Registry</keyword>
</DOC>